George Somlo, MD, medical oncologist, City of Hope, discusses treatment considerations in multiple myeloma.

Multiple myeloma patients are very well educated and often come to appointments with a list of relevant clinical trials and ask educated questions, said Somlo. That is why it is important that treatment decisions a collaborative effort between the oncologist and the patient, he says.

Oncologists should be aggressive with their treatment and think long-term when making treatment decisions. Because patients can live with multiple myeloma for many years, it should be treated like a chronic illness and treatments should be selected that are both effective and allow the patient to maintain their quality of life, says Somlo.

Videos

​George Somlo, MD, medical oncologist, City of Hope, discusses treatment considerations in multiple myeloma.

Dr. George Somlo on Treatment Considerations for Multiple Myeloma

George Somlo, MD, medical oncologist, City of Hope, discusses some of the novel agents being evaluated for the treatment of patients with multiple myeloma.

Several new agents have been approved by the FDA in the past year, and oncologists are currently learning how to best utilize them, especially in combination with one another, explains Somlo.

The overall goal, says Somlo, is to both improve the toxicity profile of some of the older agents in this space, as well as bring the novel agents into the frontline setting.

George Somlo, MD

Articles

Dr. George Somlo on Treatment Considerations for Multiple Myeloma

Dr. Somlo on Novel Agents in Multiple Myeloma